back to Australia directory
australia clinical guidance

Insomnia

Current 2026 joint Australian position-statement care for adult insomnia, including diagnosis, comorbidity assessment, CBT-I, cautious medicine use and referral.

JurisdictionAustralia
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceHealthcare professionals practising in Australia
This is an iatroX educational summary of named Australia sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Apply current TGA product information, PBS restrictions, state or territory law, local referral criteria, formulary and antimicrobial policy. A national recommendation does not create uniform service access.

Scope

Adults with acute sleep disturbance or chronic insomnia disorder. The source is the 2026 joint Australian position statement endorsed by sleep, general-practice, psychology, pharmacy and primary-care organisations. Children, pregnancy, shift-work disorder, parasomnias, narcolepsy, severe sleep-disordered breathing and insomnia secondary to an unstable psychiatric or medical emergency require population-specific assessment.
sources for this section:Australian adult insomnia statement

The Bottom Line

  • Distinguish chronic insomnia from transient poor sleep by persistent difficulty initiating or maintaining sleep, adequate opportunity for sleep and meaningful daytime impairment; use a sleep diary to establish schedule and pattern.
  • Assess obstructive sleep apnoea, restless legs, circadian disturbance, pain, menopause, mood, trauma, alcohol, caffeine, nicotine, other substances and medicines because comorbidity and mimics change care.
  • Offer cognitive behavioural therapy for insomnia as first-line treatment for chronic insomnia; its active components extend beyond sleep hygiene and require an individual, feasible plan.
  • Use brief behavioural approaches or digital delivery when appropriate and arrange trained face-to-face care for persistent, complex or high-risk illness rather than defaulting to repeated hypnotic prescriptions.
  • If medicine is considered, define the indication, expected outcome, duration, next-day impairment and stopping review and use only current Australian product information and prescribing controls.
sources for this section:Australian adult insomnia statement

Practical clinical workflow

1
Record bedtime, sleep latency, awakenings, final waking, naps, variability, daytime function and safety-critical work over at least a representative period, supported by a diary when possible.
2
Screen for snoring or witnessed apnea, excessive daytime sleepiness, urge to move the legs, abnormal sleep behaviours, mood elevation, depression, suicidality, substances and medicine timing.
3
Explain the formulation and agree a CBT-I plan that can include stimulus control, sleep consolidation, cognitive work and relaxation, adapting intensity for falls, epilepsy, bipolar disorder and driving risk.
4
If pharmacotherapy is added, retrieve the exact TGA-approved indication and product information, check other sedatives, alcohol, respiratory disease, pregnancy, liver or kidney impairment and ability to drive safely.
5
Review sleep and daytime function at a defined interval, address adherence and adverse effects, taper dependence-forming medicine safely and refer when diagnosis is uncertain or treatment response is inadequate.
sources for this section:Australian adult insomnia statement

Safety boundaries and escalation

  • Dangerous occupational or driving sleepiness, suspected severe sleep apnoea, mania, severe depression, suicidality, medication toxicity or complex sleep behaviour needs prompt specialist or emergency assessment.
  • Sleep-consolidation or restriction strategies can temporarily increase sleepiness and require modification when falls, seizure risk, bipolar activation or safety-critical tasks make harm foreseeable.
  • Combining hypnotics with alcohol, opioids or other sedatives can impair breathing, cognition and coordination; reconcile all substances and provide explicit next-day driving advice.
  • Do not stop a long-used benzodiazepine or related hypnotic abruptly when dependence is possible; use a planned taper and monitor withdrawal, rebound insomnia and relapse of the underlying condition.
sources for this section:Australian adult insomnia statement

Implementation

The 2026 joint position statement is current Australian multidisciplinary guidance and supersedes reliance on the narrow 2017 behavioural statement for this page. TGA registration, state and territory prescribing law, PBS status and local access to CBT-I remain separate implementation questions.
sources for this section:Australian adult insomnia statement

Clinical use boundary

This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.

sources for this section:Australian adult insomnia statement

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Australasian Sleep Association, Sleep Health Foundation, Royal Australian College of General Practitioners, Australian Psychological Society, Pharmaceutical Society of Australia and Australian Primary Health Care Nurses AssociationManagement of adult insomnia in Australia: A joint position statementDOI 10.1093/sleepadvances/zpag086 路 Sleep Advances, published online 2026; listed by the Australasian Sleep Association as current Australian guidance 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Australia question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.